Cyclooxygenase-1 and -2 are expressed by human T cells

Clinical and Experimental Immunology

Volumn 115, Issue 1, 1999, Pages 86-90

  Pablos, Jose L ^a   Santiago, B ^a   Carreira, P E ^a   Galindo, M ^a   Gomez Reino, J J ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Prostaglandin H2 synthase; Prostaglandins; T lymphocytes

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MESSENGER RNA;

ARTICLE; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; T LYMPHOCYTE;

ANTIBODY SPECIFICITY; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; JURKAT CELLS; MEMBRANE PROTEINS; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0032947918     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00780.x     Document Type: Article

References (26)

1. 1 Davies P, Bailey PJ, Goldenberg MM, Ford-Hutchinson AW. The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol 1984; 2:335-7.
2. 2 Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J 1991; 5:2304-12.
3. 3 Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991; 266:12866-72.
4. 4 Lee SH, Soyoola E, Chanmugam P et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992; 267:25934-8.
5. 5 Wilborn J, DeWitt DL, Peters-Golden M. Expression and role of cyclooxygenase isoforms in alveolar and peritoneal macrophages. Am J Physiol 1995; 268:L294-301.
6. 6 Geng Y, Blanco FJ, Cornelisson M, Lotz M. Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J Immunol 1995; 155:796-801.
7. 7 Masferrer JL, Zweiffel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vitro is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994; 91:3228-32.
8. 1 on adjuvant arthritis. Nature 1971; 234:304-5.
9. 9 Goodwin JS, Mesner RP, Peake GT. Prostaglandin suppression of mitogen-stimulated leukocytes in culture. J Clin Invest 1974; 54:378-83.
10. 10 Rappaport RS, Dodge J. Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 1982; 155:943-8.
11. 11 Santoli D, Phillips PD, Colt TL, Zurier RB. Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids. J Clin Invest 1990; 85:424-32.
12. 12 Flescher E, Fossum D, Gray PJ, Fernandes G, Harper MJK, Talal N. Aspirin-like drugs prime human T cells. Modulation of intracellular calcium concentrations. J Immunol 1991; 146:2553-9.
13. 13 Hsia J, Sarin N, Oliver JH, Goldstein AL. Aspirin and thymosin increase interleukin-2 and interferon-gamma production by human peripheral blood lymphocytes. Immunopharmacology 1989; 17:167-73.
14. 14 Kennedy MS, Stobo JD, Goldyne ME. In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells. Prostaglandins 1980; 20:135-45.
15. 15 Goldyne ME. Lymphocytes and arachidonic acid metabolism. Prog Allergy 1988; 44:140-52.
16. 16 Goodwin JS, Behrens T. Role of lipoxygenase metabolites of arachidonic acid in T cell activation. Ann NY Acad Sci 1988; 524:201-7.
17. 17 Hoffman T, Lizzio EF, Ting A, Marshall LA, Bonvini E, Jennings MK. Release of arachidonic acid metabolites by human monocytcs or lymphocytes: effect of treatment with interferon on stimulation by phorbol ester or calcium ionophore. Clin Immunol Immunopathol 1987; 44:82-92.
18. 18 Aussel C, Mary D, Fehlmann M. Prostaglandin synthesis in human T cells: its partial inhibition by lectins and anti-CD3 antibodies as a possible step in T cell activation. J Immunol 1987; 138:3094-9.
19. 19 Iñiguez MA, Pablos JL, Carreira PE, Cabre F, Gómez-Reino JJ. Detection of COX-1 and COX-2 isoforms in synovial fluid cells from inflammatory joint diseases. Br J Rheumatol 1998; 37:773-8.
20. 20 Ambrus JL Jr, Haneiwich S, Chesky L, McFarland P, Engler RJ. Improved in vitro antigen-specific antibody synthesis in two patients with common variable immunodeficiency taking an oral cyclooxygenase and lipoxygenase inhibitor (ketoprofen). J Allergy Clin Immunol 1991; 88:775-83.
21. 21 Blomgren H, Rotstein S, Wasserman J, Petrini B, Hammarstrom S. In vitro capacity of various cyclooxygenase inhibitors to revert immune suppression caused by radiation therapy for breast cancer. Radiother Oncol 1990; 19:329-35.
22. 22 Wachsman M, Aurelian L, Burnett JW. The prophylactic use of cyclooxygenase inhibitors in recurrent herpes simplex infections. Br J Dermatol 1990; 123:375-80.
23. 23 Hernandez-Garcia C, Fernandez-Gutierrez B, Morado I, Bañares AA, Jover JA. The CD69 activation pathway in rheumatoid arthritis synovial fluid T cells. Arthritis Rheum 1996; 39:1277-86.
24. 24 Siegle I, Klein T, Backman JT, Saal JG, Nusing RM, Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 1998; 41:122-9.
25. 25 Abramson S, Korchak H, Ludewig R et al. Modes of action of aspirin-like drugs. Proc Natl Acad Sci USA 1985; 82:7227-31.
26. 26 Ballif BA, Mincek NV, Barratt JT, Wilson ML, Simmons DL. Interaction of cyclooxygenases with an apoptosis-and autoimmunity-associated protein. Proc Natl Acad Sci USA 1996; 93:5544-9.